RHS Financial’s Quest Diagnostics DGX Stock Holding History

RHS Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,980	Closed	-$408K	–	83
2022 Q1	$408K	Sell	2,980 -140	-4%	-$19.5K	0.3%	56
2021 Q4	$540K	Sell	3,120 -190	-6%	-$28.9K	0.37%	52
2021 Q3	$481K	Sell	3,310 -10	-0.3%	-$1.46K	0.35%	56
2021 Q2	$438K	Hold	3,320	–	–	0.33%	57
2021 Q1	$426K	Hold	3,320	–	–	0.36%	50
2020 Q4	$396K	Hold	3,320	–	–	0.34%	56
2020 Q3	$380K	Sell	3,320 -61	-2%	-$7.21K	0.38%	55
2020 Q2	$385K	Sell	3,381 -554	-14%	-$58.8K	0.45%	48
2020 Q1	$316K	Sell	3,935 -890	-18%	-$92.1K	0.42%	50
2019 Q4	$515K	Sell	4,825 -330	-6%	-$34.4K	0.54%	42
2019 Q3	$552K	Hold	5,155	–	–	0.65%	40
2019 Q2	$525K	Sell	5,155 -360	-7%	-$34.6K	0.66%	41
2019 Q1	$496K	Sell	5,515 -519	-9%	-$45K	0.64%	42
2018 Q4	$502K	Buy	+6,034	New	+$566K	0.72%	40

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

RHS Financial's DGX Position: Q2 2022 in Review

RHS Financial sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 2,980 shares — an estimated $408K sold.

RHS Financial first reported a position in DGX in Q4 2018 and held it in 14 quarters. The position peaked at $552K in Q3 2019. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

RHS Financial reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
RHS Financial sold 2,980 Quest Diagnostics shares in Q2 2022, an estimated $408K.
RHS Financial first reported a position in Quest Diagnostics in Q4 2018 and held it in 14 quarters.
RHS Financial's Quest Diagnostics position peaked at $552K in Q3 2019.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on RHS Financial's 13F filing for Q2 2022, filed 15 Jul 2022.